Abstract:Runt-related transcription factors (RUNXs) can serve as both transcription activators and repressors during biological development, including immune cell maturation. RUNX factors have both tumor-promoting and tumor-suppressive roles in carcinogenesis. Immune cell infiltration and the tumor immune microenvironment have been found to be key regulators in breast cancer progression, treatment response, and patient outcome. However, the relationship between the RUNX family and immune cell infiltration in breast cancer remains unclear. We performed a comprehensive analysis to reveal the role of RUNX factors in breast cancer. Analysis of patient data in the Oncomine database showed that the transcriptional levels of RUNX proteins in breast cancer were elevated. Kaplan–Meier plotter (KM plotter) analysis showed that breast cancer patients with higher expression of RUNX proteins had better survival outcomes. Through analysis of the UALCAN database, we found that the transcriptional levels of RUNX factors were significantly correlated with some breast cancer patient characteristics. cBio Cancer Genomics Portal (cBioPortal) analysis showed the proportions of different RUNX genomic alterations in various subclasses of breast cancer. We also performed gene ontology (GO) and pathway analyses for the significantly differentially expressed genes that were correlated with RUNX factors in breast cancer. TIMER database analysis showed that immune cell infiltration in breast cancer could be affected by the transcriptional level, mutation, and gene copy number of RUNX proteins. Using the Gene Set Cancer Analysis (GSCA) database, we analyzed the effects of RUNX gene methylation on the level of immune cell infiltration in breast cancer. We found that the methylation level changes of RUNX2 and RUNX3 had opposite effects on immune cell infiltration in breast cancer. We also analyzed the relationship between the methylation level of RUNX genes and the TGF-β signaling pathway using the TISIDB database. The results showed that the methylation levels of RUNX1 and RUNX3 were correlated with the expression of TGF-β1. In summary, our analysis found that the RUNX family members can influence the infiltration of various immune cells in breast cancer depending on their expression level, mutation, gene copy number, and methylation. The RUNX family is an important regulator of immune cell infiltration in breast cancer and may serve as a potential prognostic biomarker.

Investigating the in Vitro and in Vivo Effects of RUNX1 on the Proliferation, Migration, Invasion and Apoptosis of Epithelial Ovarian Carcinoma Mediated Via TGF-β/Wnt4 Signaling Pathways

MicroRNA-211 inhibits tumor growth and invasion through directly targeting RUNX 2 in osteosarcoma

Silencing over-expression of TUBA1C inhibits proliferation and invasion of human ovarian carcinoma CAOV3, SKOV3 cells

Influence of Small Interfering RNA-mediated Inhibiting Human Runt-Related Transcription Factor 2 and Galectin-3 Gene on Proliferation and Apoptosis of Glioma Cell U251

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.

Effect of Down-Regulated Transcriptional Repressor ZEB1 on the Epithelial-Mesenchymal Transition of Ovarian Cancer Cells

Inhibition of RUNX1 promotes cisplatin-induced apoptosis in ovarian cancer cells

SOX2 Targets Fibronectin 1 to Promote Cell Migration and Invasion in Ovarian Cancer: New Molecular Leads for Therapeutic Intervention.

RUNX1/miR-429 feedback loop promotes growth, metastasis, and epithelial-mesenchymal transition in oral squamous cell carcinoma by targeting ITGB1

Effects of Dynein Light Chain Tctex-type 3 on the Biological Behavior of Ovarian Cancer

The Human Immunodeficiency Virus Type-l Tat Protein Upregulates Bcl-2 Gene Expression in Jurkat T-cell Lines and Primary Peripheral Blood Mononuclear Cells

RUNX1 Predicts Poor Prognosis and Correlates with Tumor Progression in Clear Cell Renal Carcinoma

Dysregulated RUNX1 Predicts Poor Prognosis by Mediating Epithelialmesenchymal Transition in Cervical Cancer

[Expressions of VEGF/VEGFRs and Activation of STATs in Ovarian Carcinoma].

OTX1 Silencing Suppresses Ovarian Cancer Progression Through Inhibiting the JAK/STAT Signaling.

Effects of silencing hsa_circ_0015326 on proliferation, migration, invasion, and apoptosis of epithelial ovarian cancer cells

Oncogenic Role of NUPR1 in Ovarian Cancer

LncSOX4 Serves an Oncogenic Role in the Tumorigenesis of Epithelial Ovarian Cancer by Promoting Cell Proliferation and Inhibiting Apoptosis.

EFFECTS OF RUNX3 ON CELL TURNOVER IN GASTRIC CANCER AND ITS PROGNOSTIC VALUE

Runx2 silencing sensitized human renal cell carcinoma cells to ABT-737 apoptosis

Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer